We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+10.35%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$5.48B
AUM Growth
+$244M
Cap. Flow
-$178M
Cap. Flow %
-3.24%
Top 10 Hldgs %
8.16%
Holding
4,138
New
948
Increased
818
Reduced
676
Closed
1,018

Sector Composition

Rank Sector Weight
1 Financials 13.14%
2 Industrials 11.82%
3 Healthcare 9.09%
4 Consumer Discretionary 7.46%
5 Technology 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHW
1251
PUT
Charles Schwab
SCHW
$182B
$641K 0.01%
+7,700
New +$598K
SMCI icon
1252
PUT
Super Micro Computer
SMCI
$16.6B
$640K 0.01%
+78,000
New +$594K
TCVA
1253
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
$640K 0.01%
64,000
BIIB icon
1254
CALL
Biogen
BIIB
$30.9B
$637K 0.01%
+2,300
New +$650K
LITT
1255
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
$637K 0.01%
64,000
NKGN
1256
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$635K 0.01%
63,855
+19,406
+44% +$192K
WOLF icon
1257
CALL
Wolfspeed
WOLF
$1.04B
$635K 0.01%
9,200
+3,600
+64% +$319K
ESMT
1258
DELISTED
EngageSmart, Inc.
ESMT
$635K 0.01%
36,057
+20,478
+131% +$376K
TRAQ
1259
DELISTED
Trine II Acquisition Corp.
TRAQ
$631K 0.01%
61,214
PDS
1260
Precision Drilling
PDS
$946M
$628K 0.01%
+8,191
New +$591K
PHYT
1261
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$628K 0.01%
60,770
ATRA icon
1262
Atara Biotherapeutics
ATRA
$72.6M
$627K 0.01%
7,652
-7,388
-49% -$770K
ACDI
1263
DELISTED
Ascendant Digital Acquisition Corp. III
ACDI
$626K 0.01%
60,699
ERF
1264
DELISTED
Enerplus Corporation
ERF
$624K 0.01%
35,335
-13,512
-28% -$232K
V icon
1265
CALL
Visa
V
$701B
$623K 0.01%
3,000
-2,900
-49% -$585K
DSAQ
1266
DELISTED
Direct Selling Acquisition Corp.
DSAQ
$622K 0.01%
60,463
EFX icon
1267
PUT
Equifax
EFX
$22B
$622K 0.01%
3,200
+2,800
+700% +$512K
LIN icon
1268
PUT
Linde
LIN
$236B
$620K 0.01%
+1,900
New +$596K
ITCI
1269
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$619K 0.01%
11,700
-400
-3% -$20K
JD icon
1270
CALL
JD.com
JD
$43.5B
$617K 0.01%
11,000
+1,100
+11% +$55.3K
SI
1271
DELISTED
Silvergate Capital Corporation
SI
$614K 0.01%
35,310
+31,577
+846% +$1.25M
IPAXU
1272
DELISTED
Inflection Point Acquisition Corp. Units
IPAXU
$613K 0.01%
60,112
MTW icon
1273
Manitowoc
MTW
$491M
$612K 0.01%
66,758
+15,484
+30% +$141K
HFRO
1274
Highland Opportunities and Income Fund
HFRO
$407M
$610K 0.01%
59,245
-32,891
-36% -$358K
TDC icon
1275
CALL
Teradata
TDC
$2.88B
$609K 0.01%
18,100
-13,200
-42% -$425K

Similar funds

Walleye Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Walleye Capital held 4,138 positions worth $5.48B, up 4.6% from $5.24B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Walleye Capital withdrew a net $178M in Q4 2022, closing 1,018 positions and reducing 676 holdings. Its most notable exit was Expand Energy Corp Class B Warrants, an estimated $191M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 13% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Walleye Capital opened a new position in State Street SPDR S&P Retail ETF worth $43.9M.

  • Walleye Capital's largest Q4 2022 buy was State Street SPDR S&P Retail ETF: 726,921 shares worth $43.9M.
  • Walleye Capital added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $98.3M increase.
  • Walleye Capital's biggest Q4 2022 reduction was Equity Residential, cutting an estimated $20.2M.
  • Walleye Capital fully exited Expand Energy Corp Class B Warrants in Q4 2022, selling an estimated $191M.
  • Walleye Capital's ten largest holdings make up 8.2% of its $5.48B portfolio in Q4 2022.
  • Walleye Capital opened 948 new positions and closed 1,018 in Q4 2022.
  • Walleye Capital's portfolio value rose 4.6% quarter-over-quarter to $5.48B.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.